Dr. Charles G. Drake is an Associate Professor of Oncology, Urology, and Immunology at Johns Hopkins School of Medicine. Dr. Drake’s expertise is in the use of checkpoint inhibitors, the immunotherapy agents that have made such an impact in the treatment of certain solid tumors. His work has also recently been focused on the use of radiation in conjunction with checkpoint blockade.